Is soft tissue sarcoma oncolytic virus therapy available in China?

Yes. hV01 has a licensed-use pathway associated with Hainan Le City, subject to applicable medical and regulatory conditions. It is not yet available nationwide in China.

How much does soft tissue sarcoma oncolytic virus therapy cost in China?

The estimated cost is ¥64,000, approximately US$8,900, per treatment cycle. Final pricing and inclusions should be confirmed directly with the hospital.

Who may qualify for hV01 treatment?

The stated indication is soft tissue sarcoma, but detailed patient-level eligibility criteria are not specified. The treating medical team determines eligibility after reviewing the patient's medical records and clinical circumstances.

Is hV01 a proven treatment for soft tissue sarcoma?

Safety and efficacy remain under evaluation. The treatment's licensed-use status in Le City should not be interpreted as proof of efficacy or a guarantee of an individual outcome.

top of page

ChinaCurelink
a MedeboundHEALTH Company

FREE CONSULTATION

Soft Tissue Sarcoma Oncolytic Virus Therapy China: Recombinant Human IL-21 Oncolytic Poxvirus Injection (hV01) — 2026 International Patient Guide

ChinaCureLink

Mon Aug 31 2026

7 min read

Widget Didn’t Load

Check your internet and refresh this page.

If that doesn’t work, contact us.

bottom of page